# US 2026/0192108 A1 · Implantable Stimulator Device With Tissue Biasing for MRI Protection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0192108 A1
- Document ID: US20260192108A1
- Status: Published application
- Kind: A1
- Application number: 19/429,807
- Filed: 2025-12-22
- Published: 2026-07-09
- Earliest claimed: 2025-01-07
- Assignees: Boston Scientific Neuromodulation Corporation
- Applicants: Boston Scientific Neuromodulation Corporation
- Inventors: Kiran K. Gururaj; David Wagenbach; Goran N. Marnfeldt
- Web page: https://patentgrep.com/patent/US20260192108A1

## CPC

- A61N 1/08: Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)}
- A61N 1/36125: {Details of circuitry or electric components}
- A61N 1/36128: {Control systems}
- A61N 1/36142: {for improving safety}
- A61N 1/36153: {Voltage (A61N1/3616 takes precedence)}
- A61N 1/36157: {Current (A61N1/3616 takes precedence)}
- A61N 1/36062: {Spinal stimulation}
- A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease}
- A61N 1/36185: {Selection of the electrode configuration}
- A61N 1/3718: {Monitoring of or protection against external electromagnetic fields or currents}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Stimulator circuitry useable in a stimulator device is described. The stimulator circuitry features an MRI-safe mode configured to protect the device and the patient from malfunctions caused by voltages that may develop because of electromagnetic fields and gradients present in a patient’s tissue during an MRI procedure. The circuitry is configured to assert a common mode voltage to the patient’s tissue that is preferably between a ground and a compliance voltage of the stimulator device.

## Claims

### Claim 1

An implantable stimulator device configured to provide electrical stimulation to a patient, comprising:
a plurality of electrode nodes each couplable to a different electrode configured to contact the patient’s tissue,
stimulation circuitry configured to drive at least two of the electrode nodes to provide current through the tissue,
biasing circuitry configured to produce a reference voltage,
a plurality of first switches each associated with a different one of the electrode nodes, wherein each of the plurality of first switches is configured, when selected, to couple the reference voltage to its associated electrode node to provide a common mode voltage to the patient’s tissue at that node’s associated electrode, and
control circuitry configured to:
receive a command to put the stimulator device in an MRI-safe mode, and
in response to the command, closing a selected one or more of the first plurality of first switches.

### Claim 2 (depends on 1)

The device of claim 1, wherein the selected one or more of the first plurality of switches comprises a first switch associated with a case electrode.

### Claim 3 (depends on 1)

The device of claim 1, wherein the selected one or more of the first plurality of switches comprises a first switch associated with an electrode comprised upon an electrode lead that is implantable in the patient’s tissue.

### Claim 4 (depends on 1)

The device of claim 1, wherein the stimulation circuitry is configured to be powered between a compliance voltage (VH) and a ground, and wherein the reference voltage is between VH and ground.

### Claim 5 (depends on 4)

The device of claim 4, wherein the reference voltage is VH/2.

### Claim 6 (depends on 4)

The device of claim 4, wherein the control circuitry is configured to increase VH upon receipt of the command to put the stimulator device in an MRI-safe mode.

### Claim 7 (depends on 1)

The device of claim 1, wherein the biasing circuitry comprises a high impedance driver circuitry and a programmable driver circuitry.

### Claim 8 (depends on 7)

The device of claim 7, wherein the high impedance driver circuitry comprises a voltage divider.

### Claim 9 (depends on 7)

The device of claim 7, wherein the programmable driver circuitry comprises an amplifier configured to produce the reference voltage.

### Claim 10 (depends on 9)

The device of claim 9, wherein the amplifier is configured to receive a programmable input bias current that may be programmably selected to control a drive strength of the reference voltage.

### Claim 11 (depends on 7)

The device of claim 7, wherein the control circuitry is configured to select between the high impedance driver circuitry and the programmable driver circuitry in the MRI-safe mode.

### Claim 12 (depends on 1)

The device of claim 1, wherein the control circuitry is configured to cause the device to cease providing stimulation when in the MRI-safe mode.

### Claim 13 (depends on 1)

The device of claim 1, wherein the device is configured to provide stimulation at selected one or more of the electrode nodes when the device is in the MRI-safe mode.

### Claim 14 (depends on 13)

The device of claim 13, wherein the stimulation comprises at least one active stimulation duration during which the stimulation circuitry actively drives current at at least two selected stimulation electrode nodes, and wherein the control circuitry is configured to:
select the at least two stimulation electrode nodes, and
select one or more biasing electrode nodes for providing the common mode voltage to the patient’s tissue.

### Claim 15 (depends on 14)

The device of claim 14, wherein the control circuitry is configured to, in response to the command to put the stimulator device in an MRI-safe mode close the one or more of the plurality of first switches for the biasing electrode nodes.

### Claim 16 (depends on 15)

The device of claim 15, wherein the control circuitry is configured to cause the stimulation circuitry to drive the at least two stimulation electrode nodes during the stimulation duration.

### Claim 17 (depends on 15)

The device of claim 15, wherein the control circuitry is configured to select between the high impedance driver circuitry and the programmable driver circuitry in response to the command to put the MRI-safe mode.

### Claim 18 (depends on 14)

The device of claim 14, wherein the stimulation comprises at least one passive charge recovery duration during which the stimulation does not drive the at least two stimulation electrode nodes, and wherein the control circuitry is configured to close second switches coupled to the at least two stimulation electrode nodes during the passive charge recovery duration to drain charge from DC-blocking capacitors coupled to the at least two stimulation electrode nodes.

### Claim 19 (depends on 18)

The device of claim 18, wherein the control circuitry is configured to close second switches coupled to the one or more biasing electrode nodes during the passive charge recovery duration to drain charge from DC-blocking capacitors coupled to the biasing electrode nodes.

### Claim 20 (depends on 1)

The device of claim 1, wherein the command to put the stimulator device in an MRI-safe mode is responsive to a sensed magnetic field.
